Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis

John Zhong Li, Yongcheng Huang, Ruchan Karaman, Pavlina T. Ivanova, H. Alex Brown, Thomas Roddy, Jose Castro-Perez, Jonathan C. Cohen, Helen H. Hobbs

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

A genetic variant in PNPLA3 (PNPLA3 I148M), a triacylglycerol (TAG) hydrolase, is a major risk factor for non-alcoholic fatty liver disease (NAFLD); however, the mechanism underlying this association is not known. To develop an animal model of PNPLA3-induced fatty liver disease, we generated transgenic mice that overexpress similar amounts of wild-type PNPLA3 (PNPLA3 WT) or mutant PNPLA3 (PNPLA3 I148M) either in liver or adipose tissue. Overexpression of the transgenes in adipose tissue did not affect liver fat content. Expression of PNPLA3I 148M, but not PNPLA3 WT, in liver recapitulated the fatty liver phenotype as well as other metabolic features associated with this allele in humans. Metabolic studies provided evidence for 3 distinct alterations in hepatic TAG metabolism in PNPLA3 I148Mtransgenic mice: increased formation of fatty acids and TAG, impaired hydrolysis of TAG, and relative depletion of TAG long-chain polyunsaturated fatty acids. These findings suggest that PNPLA3 plays a role in remodeling TAG in lipid droplets, as they accumulate in response to food intake, and that the increase in hepatic TAG levels associated with the I148M substitution results from multiple changes in hepatic TAG metabolism. The development of an animal model that recapitulates the metabolic phenotype of the allele in humans provides a new platform in which to elucidate the role of PNLPA3 I148M in NAFLD.

Original languageEnglish (US)
Pages (from-to)4130-4144
Number of pages15
JournalJournal of Clinical Investigation
Volume122
Issue number11
DOIs
StatePublished - Nov 1 2012

Fingerprint

Triglycerides
Liver
Fatty Liver
Adipose Tissue
Animal Models
Alleles
Phenotype
Lipase
Unsaturated Fatty Acids
Transgenes
Transgenic Mice
Liver Diseases
Hydrolysis
Fatty Acids
Eating
Fats
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis. / Li, John Zhong; Huang, Yongcheng; Karaman, Ruchan; Ivanova, Pavlina T.; Brown, H. Alex; Roddy, Thomas; Castro-Perez, Jose; Cohen, Jonathan C.; Hobbs, Helen H.

In: Journal of Clinical Investigation, Vol. 122, No. 11, 01.11.2012, p. 4130-4144.

Research output: Contribution to journalArticle

Li, JZ, Huang, Y, Karaman, R, Ivanova, PT, Brown, HA, Roddy, T, Castro-Perez, J, Cohen, JC & Hobbs, HH 2012, 'Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis', Journal of Clinical Investigation, vol. 122, no. 11, pp. 4130-4144. https://doi.org/10.1172/JCI65179
Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T et al. Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis. Journal of Clinical Investigation. 2012 Nov 1;122(11):4130-4144. https://doi.org/10.1172/JCI65179
Li, John Zhong ; Huang, Yongcheng ; Karaman, Ruchan ; Ivanova, Pavlina T. ; Brown, H. Alex ; Roddy, Thomas ; Castro-Perez, Jose ; Cohen, Jonathan C. ; Hobbs, Helen H. / Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis. In: Journal of Clinical Investigation. 2012 ; Vol. 122, No. 11. pp. 4130-4144.
@article{bad75e2c4d5d47a4b54b35b6645900c1,
title = "Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis",
abstract = "A genetic variant in PNPLA3 (PNPLA3 I148M), a triacylglycerol (TAG) hydrolase, is a major risk factor for non-alcoholic fatty liver disease (NAFLD); however, the mechanism underlying this association is not known. To develop an animal model of PNPLA3-induced fatty liver disease, we generated transgenic mice that overexpress similar amounts of wild-type PNPLA3 (PNPLA3 WT) or mutant PNPLA3 (PNPLA3 I148M) either in liver or adipose tissue. Overexpression of the transgenes in adipose tissue did not affect liver fat content. Expression of PNPLA3I 148M, but not PNPLA3 WT, in liver recapitulated the fatty liver phenotype as well as other metabolic features associated with this allele in humans. Metabolic studies provided evidence for 3 distinct alterations in hepatic TAG metabolism in PNPLA3 I148Mtransgenic mice: increased formation of fatty acids and TAG, impaired hydrolysis of TAG, and relative depletion of TAG long-chain polyunsaturated fatty acids. These findings suggest that PNPLA3 plays a role in remodeling TAG in lipid droplets, as they accumulate in response to food intake, and that the increase in hepatic TAG levels associated with the I148M substitution results from multiple changes in hepatic TAG metabolism. The development of an animal model that recapitulates the metabolic phenotype of the allele in humans provides a new platform in which to elucidate the role of PNLPA3 I148M in NAFLD.",
author = "Li, {John Zhong} and Yongcheng Huang and Ruchan Karaman and Ivanova, {Pavlina T.} and Brown, {H. Alex} and Thomas Roddy and Jose Castro-Perez and Cohen, {Jonathan C.} and Hobbs, {Helen H.}",
year = "2012",
month = "11",
day = "1",
doi = "10.1172/JCI65179",
language = "English (US)",
volume = "122",
pages = "4130--4144",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "11",

}

TY - JOUR

T1 - Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis

AU - Li, John Zhong

AU - Huang, Yongcheng

AU - Karaman, Ruchan

AU - Ivanova, Pavlina T.

AU - Brown, H. Alex

AU - Roddy, Thomas

AU - Castro-Perez, Jose

AU - Cohen, Jonathan C.

AU - Hobbs, Helen H.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - A genetic variant in PNPLA3 (PNPLA3 I148M), a triacylglycerol (TAG) hydrolase, is a major risk factor for non-alcoholic fatty liver disease (NAFLD); however, the mechanism underlying this association is not known. To develop an animal model of PNPLA3-induced fatty liver disease, we generated transgenic mice that overexpress similar amounts of wild-type PNPLA3 (PNPLA3 WT) or mutant PNPLA3 (PNPLA3 I148M) either in liver or adipose tissue. Overexpression of the transgenes in adipose tissue did not affect liver fat content. Expression of PNPLA3I 148M, but not PNPLA3 WT, in liver recapitulated the fatty liver phenotype as well as other metabolic features associated with this allele in humans. Metabolic studies provided evidence for 3 distinct alterations in hepatic TAG metabolism in PNPLA3 I148Mtransgenic mice: increased formation of fatty acids and TAG, impaired hydrolysis of TAG, and relative depletion of TAG long-chain polyunsaturated fatty acids. These findings suggest that PNPLA3 plays a role in remodeling TAG in lipid droplets, as they accumulate in response to food intake, and that the increase in hepatic TAG levels associated with the I148M substitution results from multiple changes in hepatic TAG metabolism. The development of an animal model that recapitulates the metabolic phenotype of the allele in humans provides a new platform in which to elucidate the role of PNLPA3 I148M in NAFLD.

AB - A genetic variant in PNPLA3 (PNPLA3 I148M), a triacylglycerol (TAG) hydrolase, is a major risk factor for non-alcoholic fatty liver disease (NAFLD); however, the mechanism underlying this association is not known. To develop an animal model of PNPLA3-induced fatty liver disease, we generated transgenic mice that overexpress similar amounts of wild-type PNPLA3 (PNPLA3 WT) or mutant PNPLA3 (PNPLA3 I148M) either in liver or adipose tissue. Overexpression of the transgenes in adipose tissue did not affect liver fat content. Expression of PNPLA3I 148M, but not PNPLA3 WT, in liver recapitulated the fatty liver phenotype as well as other metabolic features associated with this allele in humans. Metabolic studies provided evidence for 3 distinct alterations in hepatic TAG metabolism in PNPLA3 I148Mtransgenic mice: increased formation of fatty acids and TAG, impaired hydrolysis of TAG, and relative depletion of TAG long-chain polyunsaturated fatty acids. These findings suggest that PNPLA3 plays a role in remodeling TAG in lipid droplets, as they accumulate in response to food intake, and that the increase in hepatic TAG levels associated with the I148M substitution results from multiple changes in hepatic TAG metabolism. The development of an animal model that recapitulates the metabolic phenotype of the allele in humans provides a new platform in which to elucidate the role of PNLPA3 I148M in NAFLD.

UR - http://www.scopus.com/inward/record.url?scp=84868609657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868609657&partnerID=8YFLogxK

U2 - 10.1172/JCI65179

DO - 10.1172/JCI65179

M3 - Article

VL - 122

SP - 4130

EP - 4144

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 11

ER -